secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2021-10-07T23:59:59+00:00
Accession:  0001493152-21-024884
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte names Gisela Paulsen COO effective Oct 4, 2021; salary $390k, options
------------------------------------------------------------------------------

- Gisela Paulsen appointed Chief Operating Officer, effective October 4, 2021.
- Annual salary of $390,000 with target bonus of 50% of base salary.
- One-time sign-on award of 375,000 stock options vesting over four years.
- Previously General Manager of Exact Sciences' Precision Oncology and senior roles at Roche/Genentech.
- Severance agreement provides 12 months base salary and accelerated vesting upon certain terminations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315221024884/0001493152-21-024884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315221024884/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-024884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer